Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin
Annals of Clinical Microbiology and Antimicrobials, cilt.8, 2009 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 8
- Basım Tarihi: 2009
- Doi Numarası: 10.1186/1476-0711-8-12
- Dergi Adı: Annals of Clinical Microbiology and Antimicrobials
- Derginin Tarandığı İndeksler: Scopus
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Intravesical administration of Bacillus Calmette-Guérin is used as a treatment method in superficial bladder cancer. While it is generally well tolerated, serious side effects may develop. Granulomatous hepatitis cases have been previously reported; however, only one case with tuberculous peritonitis exists in the current literature. We hereby present two cases, one of which is the second tubercular peritonitis case following Bacillus Calmette-Guérin treatment to be reported, and the other a case with granulomatous hepatitis. Complete cure was achieved in both cases with specific therapy. In the patient who developed peritonitis, intravesical Bacillus Calmette-Guérin therapy was recommenced after antituberculosis treatment, and completed without further complications. © 2009 Soylu et al; licensee BioMed Central Ltd.